Pulmonary interstitial emphysema is a lung problem in which air leaks out of the tiny air sacs and into the lung tissue. It most often affects premature babies who need breathing support, especially in the first days of life. Not everyone will have the same experience, but pulmonary interstitial emphysema can cause fast breathing, low oxygen levels, and trouble getting enough air in and out. It can be short term and improve over days to weeks, but severe cases can be life-threatening, especially in very small or very sick newborns. Treatment focuses on protecting the lungs with gentle ventilator settings, careful positioning, and sometimes extra procedures if pulmonary interstitial emphysema does not improve.
How many people live with Pulmonary interstitial emphysema?
Global and U.S. population estimates for pulmonary interstitial emphysema are not consistently reported by a single authoritative source. This rare lung air leak is usually counted as a short-term complication in premature babies receiving intensive care, so medical reports tend to give hospital-based rates in high-risk newborns rather than a worldwide or U.S. total of people living with it.
Overview
Pulmonary interstitial emphysemaSymptoms
Pulmonary interstitial emphysema can make breathing suddenly harder, with fast breathing, grunting, bluish lips, and low oxygen levels. In babies, early symptoms of pulmonary interstitial emphysema often include increasing trouble breathing and a need for more oxygen or breathing support.
Outlook and prognosis
The outlook for pulmonary interstitial emphysema depends on how severe it is and the lung problem causing it. Many babies improve as trapped air gradually clears with careful breathing support. Prognosis is often best when it is found early and stays limited.
Causes and risk factors
Pulmonary interstitial emphysema usually results from air leaking into lung tissue after pressure-related injury, most often in premature babies with fragile lungs. Risk rises with mechanical ventilation, high airway pressures, severe lung disease, very low birth weight, and extreme prematurity.
Genetic influences
Genetics do not appear to play a major role in pulmonary interstitial emphysema. It is usually linked to lung injury and pressure from breathing support, especially in premature babies, rather than inherited gene changes.
Diagnosis
Pulmonary interstitial emphysema is usually diagnosed with chest imaging, especially X-rays. Doctors combine the imaging pattern with breathing problems, oxygen needs, and ventilator history. Sometimes CT helps when the diagnosis of pulmonary interstitial emphysema is unclear.
Treatment and drugs
Treatment for pulmonary interstitial emphysema focuses on lowering pressure in the lungs. Many babies improve with gentler ventilator settings, careful oxygen, and sometimes positioning on one side. Severe pulmonary interstitial emphysema may need high-frequency ventilation or a chest procedure.
Symptoms
Pulmonary interstitial emphysema often shows up in premature or very sick newborns as breathing suddenly becomes harder. Loved ones often notice the changes first. A baby may breathe faster, need more oxygen, or tire during routine care. Not every baby has every sign, and the early symptoms of pulmonary interstitial emphysema can overlap with other newborn lung problems.
Breathing can become very rapid, sometimes over minutes to hours. A baby may seem to pant or take many breaths in a short time.
The chest may pull in between or below the ribs, the nostrils may flare, and soft grunting sounds can happen. These signs mean breathing is taking more effort than usual.
Oxygen levels may drop, and the lips, tongue, or skin can look bluish, gray, or unusually pale. In pulmonary interstitial emphysema, this can happen even in a baby who seemed fairly stable before.
A baby on oxygen or a ventilator may suddenly need higher settings to stay comfortable and keep oxygen levels up. Among the early symptoms of pulmonary interstitial emphysema, this is often one of the clearest warning signs for the care team.
How people usually first notice Pulmonary interstitial emphysema?
Pulmonary interstitial emphysema is usually first noticed when a premature or very sick newborn on breathing support suddenly seems harder to oxygenate, needs more help from the ventilator, or develops faster breathing and visible chest retractions, meaning the skin pulls in around the ribs with each breath. Doctors may first suspect it after a chest X-ray shows air leaking out of the tiny air sacs and tracking through the lung tissue, often in a baby whose breathing had already been fragile because of lung immaturity or severe lung disease. In other words, the first signs of pulmonary interstitial emphysema are often a change in breathing status and oxygen needs rather than something a family can easily see on its own.
Types of Pulmonary interstitial emphysema
Different types of pulmonary interstitial emphysema are mainly described by how much of the lung is involved and how long the air leak lasts. In newborns, especially babies born early, this can change how hard it is to breathe and how much oxygen or breathing support is needed. Symptoms don’t always look the same for everyone. Some babies become suddenly more short of breath while on a ventilator, while others have a more persistent form that improves more slowly.
Diffuse PIE
Air leaks through much of one or both lungs, so breathing problems are often more severe. Babies may need more oxygen, faster breathing support, or higher ventilator settings, and chest imaging usually shows more widespread changes.
Localized PIE
Air is trapped in a smaller part of the lung rather than spread widely. Symptoms may be milder at first, but if the affected area grows, it can still press on nearby lung tissue and make breathing harder.
Persistent PIE
This form lasts longer instead of clearing over a short period, and it is one of the more recognized variants of pulmonary interstitial emphysema. Many living with this form continue to have trouble coming off breathing support, and the air leak can keep recurring or remain visible on imaging.
Can I slow down the onset of symptoms?
Usually, no; there is no good evidence that lifestyle changes can meaningfully delay the start of pulmonary interstitial emphysema, because this is usually an air leak problem that happens in very premature or very sick babies while they are receiving breathing support. The main ways doctors try to lower risk are medical, not lifestyle-based: careful use of breathing machines, using the lowest pressure that still helps the baby breathe, and close monitoring in the newborn intensive care unit, but these steps reduce risk rather than prevent the condition for sure. If your baby is at risk, working closely with the care team can help them respond early and choose the safest support possible.
What genetics can tell you about symptoms
For pulmonary interstitial emphysema, genetics usually does not tell you much about which symptoms will happen, how severe they will be, or when they start, because this is mainly a lung injury linked to fragile lungs and pressure from breathing support, most often in premature babies. In day-to-day terms, symptoms are driven more by how early a baby was born, how sick the lungs are, and how much breathing help is needed than by inherited gene changes. Rare genetic conditions that affect lung development may change a baby’s overall lung health, but they are not a usual explanation for the symptoms of pulmonary interstitial emphysema itself.
Causes and risk factors
Pulmonary interstitial emphysema usually happens when fragile lungs are stretched too much and tiny air sacs tear. It is most common in premature babies with very immature lungs or low birth weight. A major environmental risk is needing a ventilator or other breathing support that uses high pressure. Other biological risks include severe breathing distress, lung infection, and meconium aspiration. Doctors look at several causes and risk factors for pulmonary interstitial emphysema because it is rarely just one factor, and genetic or lifestyle factors are not known to be major direct causes.
What are the most common causes or risk factors?
Pulmonary interstitial emphysema most often happens in premature or very low birth weight babies because their lungs are still fragile and not fully developed. The biggest risk is needing breathing support with positive pressure, especially a ventilator, and the risk is higher when a baby already has lung problems such as newborn breathing distress, meconium breathing into the lungs, or a lung infection. There is no common well-proven inherited or genetic cause, so for most families this is linked to early birth and lung injury rather than something passed down in the family.
Environmental and biological risk factors
Pulmonary interstitial emphysema happens when air leaks out of the tiny air sacs and tracks into the supporting tissue of the lungs, most often in newborns who already have fragile lungs. Doctors often group risks into internal (biological) and external (environmental). For many families looking up risk factors for pulmonary interstitial emphysema in premature infants, the biggest ones are prematurity, serious breathing illness, and breathing support that uses higher pressures.
Premature babies have less mature, more delicate lung tissue, so the air spaces can tear more easily. The earlier a baby is born, the higher the risk of pulmonary interstitial emphysema tends to be.
Very small babies often have especially fragile lungs and may need more breathing support in the first days of life. That combination can raise the chance of pulmonary interstitial emphysema.
A ventilator can be lifesaving, but higher airway pressures or larger breaths can overdistend parts of the lung. This makes air leaks, including pulmonary interstitial emphysema, more likely.
Other positive-pressure support, such as CPAP or forceful bag-mask ventilation during resuscitation, can also increase stress on delicate lungs. The risk is usually highest when the lungs are already immature or inflamed.
Genetic risk factors
When families ask about the genetic causes of pulmonary interstitial emphysema, the main point is that no single inherited cause has been clearly proven. Pulmonary interstitial emphysema does not usually run strongly in families, but a few rare inherited lung conditions may make lung tissue more fragile and raise the chance of this air-leak problem. Genetic risk is most relevant when it appears with unusually severe newborn breathing disease, other birth differences, or a family history of similar illness.
No proven gene: No common inherited gene change has been shown to directly cause pulmonary interstitial emphysema. For most families, this means it is not considered a clearly inherited disorder.
Surfactant disorders: Rare inherited problems with surfactant, the material that helps tiny air sacs stay open, can make the lungs less stable. In some newborns, that added fragility may make pulmonary interstitial emphysema more likely.
Lung development genes: Some very rare genetic conditions affect how the lungs form and function before or just after birth. When lung tissue is unusually delicate, air-leak problems can happen more easily.
Family history: A family history of unexplained severe newborn lung disease can suggest an underlying inherited condition. If that pattern is present, doctors may consider genetic testing to look for a rare lung disorder.
Lifestyle risk factors
Direct lifestyle risk factors for pulmonary interstitial emphysema are limited, because this condition is usually driven more by prematurity and intensive breathing support than by everyday habits. Still, some maternal habits before and during pregnancy can increase the chance of preterm birth or fragile newborn lungs, which can make pulmonary interstitial emphysema more likely. When people ask about lifestyle risk factors for pulmonary interstitial emphysema, the most relevant factors are those that affect fetal growth, timing of birth, and early lung resilience.
Smoking or vaping during pregnancy can impair fetal lung development and increase the risk of prematurity. That can leave a newborn more vulnerable to air leak problems, including pulmonary interstitial emphysema.
Heavy alcohol use or non-medical drug use during pregnancy can raise the risk of preterm delivery and serious newborn breathing problems. Those complications can increase the need for respiratory support, which is closely linked to pulmonary interstitial emphysema.
Inadequate maternal nutrition can contribute to poor fetal growth and a higher risk of preterm birth. Smaller, more medically fragile infants may have less resilient lungs and a greater chance of developing pulmonary interstitial emphysema when breathing support is needed.
Severe inactivity together with uncontrolled weight gain or poor metabolic health in pregnancy can increase the risk of complications such as preterm delivery. That indirect pathway matters because earlier birth often means more immature lungs and a higher risk of pulmonary interstitial emphysema.
Risk prevention
Pulmonary interstitial emphysema is usually not something families can fully prevent on their own, because it most often affects premature or very ill newborns who need breathing support. Prevention mainly means lowering pressure-related lung injury, especially in babies with fragile lungs. Some prevention is universal, others are tailored to people with specific risks.
Lowering the chance of very early delivery can also lower the risk of pulmonary interstitial emphysema. Good prenatal care, managing infections and high blood pressure, and avoiding smoking or vaping during pregnancy can all help protect a baby’s lungs before birth.
If preterm birth looks likely, steroid treatment during pregnancy can help the baby’s lungs mature faster. This can reduce severe breathing distress after birth and may lower the need for higher-pressure ventilation that can lead to pulmonary interstitial emphysema.
In babies who need respiratory help, the goal is to use the lowest effective pressures and oxygen levels. Careful ventilator settings and, when appropriate, noninvasive support such as CPAP can reduce the risk of air leaking into lung tissue.
Premature babies often have stiff, underdeveloped lungs, which makes pressure injury more likely. Early treatment of breathing distress, including surfactant when needed, can help the lungs open more evenly and lower the risk of pulmonary interstitial emphysema.
Can you prevent Pulmonary interstitial emphysema?
Not always. Pulmonary interstitial emphysema most often happens in very premature or very sick newborns who need help breathing, so families usually cannot fully prevent it themselves. The risk may be lowered in the hospital by using the gentlest breathing support possible and watching closely to avoid too much pressure in the lungs, but it can still happen even with good care.
Transmission
Pulmonary interstitial emphysema is not an infection, so it cannot be passed from one baby or person to another through the air, touch, or body fluids. It is also not usually something inherited from a parent. Instead, pulmonary interstitial emphysema happens when tiny air spaces in the lungs become overstretched or tear, letting air leak into the tissue around them, most often in premature babies or babies who need breathing support. If you are wondering whether pulmonary interstitial emphysema is contagious, the answer is no; how serious it is depends on the amount of leaked air and the underlying lung problem, not on any risk of spread.
When to test your genes
Genetic testing is not usually part of early detection or routine care for pulmonary interstitial emphysema. This condition most often develops from lung injury and pressure from breathing support, especially in premature newborns, so treatment is guided by the baby’s symptoms, imaging, and neonatal care rather than inherited gene results.
Diagnosis
Pulmonary interstitial emphysema is usually diagnosed in babies who are already having breathing problems, often in a neonatal intensive care unit. It tends to be suspected when a premature baby or a baby on breathing support suddenly needs more oxygen or seems harder to ventilate. Doctors usually begin with the baby’s symptoms, exam findings, and chest imaging, because the diagnosis of pulmonary interstitial emphysema is mainly based on how the lungs look and how the baby is breathing.
Doctors look at whether the baby was born early, has needed a ventilator, or has had other lung problems such as respiratory distress. These details help show how likely an air leak condition like pulmonary interstitial emphysema may be.
The care team checks breathing rate, chest movement, oxygen levels, and how much work each breath takes. They also listen for reduced or uneven breath sounds, which can suggest trapped air in part of the lung.
This is the main test used to diagnose pulmonary interstitial emphysema. The X-ray may show tiny streaks or small bubble-like pockets of air spreading through the lung tissue, sometimes more on one side than the other.
Repeat chest X-rays are often done to see whether the air leak is getting better, staying the same, or spreading. Some diagnoses are clear after a single visit, while others take more time, especially when lung findings overlap with other newborn breathing conditions.
How is Pulmonary interstitial emphysema diagnosed?
Pulmonary interstitial emphysema is usually diagnosed by a doctor looking at a baby’s breathing problems together with the medical history, especially in a premature newborn who needs a breathing machine or extra pressure to help the lungs work. The main test is a chest X-ray, which can show air leaking into the tissue around the tiny air sacs instead of staying where it should inside the lungs. If the X-ray is not clear, doctors may use other imaging tests and closely watch oxygen levels and breathing to confirm the diagnosis and rule out other lung problems.
Stages of Pulmonary interstitial emphysema
Pulmonary interstitial emphysema does not have defined progression stages. This is because it is usually an air leak problem that can appear suddenly and change from hour to hour, rather than a condition that moves through set steps over time. Doctors usually start with a conversation about breathing problems and then confirm the diagnosis with chest imaging, especially X-rays, while also watching oxygen levels and the work of breathing. In babies, the early symptoms of pulmonary interstitial emphysema can include fast breathing, low oxygen, and increasing trouble getting enough air in and out, so close monitoring in the hospital is often needed.
Outlook and prognosis
The outlook for pulmonary interstitial emphysema varies widely and depends mainly on how premature or medically fragile the patient is, how extensive the air leak is, and whether it improves with changes in ventilation. In many infants, especially when the condition is recognized early and managed with lung-protective strategies, it can resolve over days to weeks without lasting major problems. More severe or persistent cases can lead to prolonged respiratory failure, chronic lung disease such as bronchopulmonary dysplasia, recurrent air leaks, and a longer stay in intensive care. Mortality is not caused by pulmonary interstitial emphysema alone in most cases, but the condition is associated with a higher risk of death in extremely premature newborns and in those with severe underlying lung disease or other critical complications. Survivors may recover fully, but the smallest and sickest infants have a greater chance of ongoing breathing issues and other complications related to prematurity.
Long-term effects
For many families, pulmonary interstitial emphysema is most intense in the newborn period, but its effects can sometimes last beyond that. The long-term effects of pulmonary interstitial emphysema depend a lot on how premature a baby is, how severe the air leak becomes, and whether other lung problems are present at the same time. Long-term effects vary widely, with some infants recovering with little lasting trouble while others develop ongoing breathing issues related to lung injury and prematurity. In day-to-day life, this can mean anything from normal breathing after discharge to months of extra oxygen, frequent checkups, or easier tiring with feeds and respiratory infections.
Some babies who have had pulmonary interstitial emphysema go on to develop chronic lung disease, also called bronchopulmonary dysplasia. This can mean fast breathing, extra work to breathe, and lower oxygen levels for weeks or months after the air leak itself has improved.
If the lungs stay irritated or underdeveloped, some infants need oxygen for a longer time, including after leaving the hospital. The need often improves as the lungs grow, but in more severe cases it can last for months.
Many living with pulmonary interstitial emphysema have a higher chance of wheezing, breathing trouble during colds, or readmission to the hospital in infancy. A simple viral infection may hit harder because the lungs have less reserve.
In more severe cases, trapped air can overstretch parts of the lung and leave areas that do not work as evenly as expected. Over time, this may contribute to reduced lung function or an uneven appearance on chest imaging.
How is it to live with Pulmonary interstitial emphysema?
Pulmonary interstitial emphysema is usually not a condition people “live with” in the long term so much as a serious breathing problem that happens during intensive care, most often in premature or very ill newborns whose fragile lungs are already under strain. Day to day, this can mean close monitoring in the NICU, help from breathing machines, careful positioning, and frequent adjustments by the medical team to protect the lungs while still getting enough oxygen into the body. For parents and loved ones, the experience can be exhausting and frightening, with long hours at the bedside and a lot of uncertainty, but many find that clear communication with the care team and steady support make an overwhelming situation more manageable.
Treatment and drugs
Pulmonary interstitial emphysema is treated by lowering the pressure on the lungs and giving the trapped air time to clear, which often means adjusting breathing support, lowering ventilator settings, or sometimes using a gentler type of ventilation. In babies with more severe pulmonary interstitial emphysema, doctors may place them in a position that helps protect the healthier lung, give extra oxygen as needed, and closely monitor breathing, heart rate, and blood oxygen levels. Treatment plans often combine several approaches. If one area of the lung is much more affected, some infants may need a breathing tube placed more selectively, drainage of an air leak, or, rarely, surgery to remove badly damaged lung tissue.
Can you cure Pulmonary interstitial emphysema?
There is no single medicine that cures pulmonary interstitial emphysema, a type of lung air leak, but it can often improve or go away when doctors treat the cause and support breathing very carefully. Treatment usually focuses on protecting the lungs while they heal, which may include changing ventilator settings, giving oxygen, and other hospital care. How much it improves can vary, especially in babies born very early or those who are already very sick.
Non-drug treatment
Pulmonary interstitial emphysema often affects premature or very sick newborns who need breathing support, so treatment usually focuses on protecting the lungs while the air leak settles. In daily care, this can mean adjusting how a baby is positioned, changing the type of breathing support, and using careful monitoring in the neonatal intensive care unit. Managing pulmonary interstitial emphysema often means using the gentlest approach that keeps oxygen levels safe while reducing further lung stretch. The best plan depends on how severe the air leak is and whether it affects one lung or both.
Breathing support is usually adjusted to use the lowest pressure and smallest breaths that still provide enough oxygen. This can help limit extra air leaking into lung tissue and give the lungs time to heal.
Some babies do better with very fast, very small breaths instead of standard ventilator breaths. This approach may be used when early treatment for pulmonary interstitial emphysema is needed because it can reduce lung overexpansion.
Lying with the affected lung down may help reduce air leak in some babies, especially when one side is more involved. For many, treatment begins not at the pharmacy, but with small bedside changes like careful positioning and close reassessment.
If one lung is much more affected, the breathing tube may sometimes be guided to mainly support the healthier lung for a short time. This can let the more injured side rest and may allow trapped air to clear.
Your genes may have an impact on how drugs work for you
For pulmonary interstitial emphysema, genes are not known to play a clear, routine role in how treatment works, because care usually focuses more on breathing support and careful changes to the ventilator than on medicines. If medicines are used, they are usually to support the baby’s overall care rather than to treat the air leak itself, and there are no well-established genetic tests that doctors commonly use to guide those drug choices. In other words, unlike some conditions where a gene change can help predict which medicine may work best or cause side effects, that is not a standard part of care for people living with pulmonary interstitial emphysema.
Pharmacological treatments
Pulmonary interstitial emphysema is usually not treated with a single drug that removes the trapped air. In practice, treatment for pulmonary interstitial emphysema in newborns focuses mostly on breathing support, while medicines are used to treat related problems or make ventilation safer and gentler. Not everyone responds to the same medication in the same way. The exact choice depends on prematurity, lung disease, infection risk, and how much breathing help is needed.
Surfactant medicines such as poractant alfa, beractant, or calfactant may be given if a premature baby also has respiratory distress syndrome. These drugs do not directly cure pulmonary interstitial emphysema, but they can help the lungs work better and sometimes reduce the pressure needed on the ventilator.
Morphine or fentanyl may be used to ease discomfort and help a baby breathe more smoothly with the ventilator. This can lower struggling against the machine, which may help limit further air leak in some cases.
In severe cases, medicines such as vecuronium or pancuronium may be used for a short time to fully relax the breathing muscles. These are used very carefully in intensive care when gentler, more controlled ventilation is needed.
Antibiotics such as ampicillin and gentamicin may be started if there is concern for pneumonia or another infection. They do not treat pulmonary interstitial emphysema itself, but treating infection can be an important part of overall lung care.
Genetic influences
When a newborn needs oxygen or a ventilator, the lungs can be under a lot of stress, and pulmonary interstitial emphysema usually develops because of that stress rather than because it runs in families. Genetics is only one piece of the puzzle, but rare inherited conditions that affect surfactant, the substance that helps keep the air sacs open, or other parts of lung development may make the lungs more fragile and more likely to develop air leaks like pulmonary interstitial emphysema. This is one reason doctors sometimes look more closely at family history when pulmonary interstitial emphysema happens in a full-term baby, keeps coming back, or appears alongside other unusual lung problems. In those situations, genetic testing may be considered to help explain why pulmonary interstitial emphysema happened and whether there could be a broader lung disorder behind it. For most families, though, pulmonary interstitial emphysema is not thought of as a classic inherited disease, and the main risks are still prematurity, lung immaturity, and the need for breathing support.
Is Pulmonary interstitial emphysema genetic?
Genetics do not appear to play a major role in pulmonary interstitial emphysema. It is usually linked to lung injury and pressure from breathing support, especially in premature babies, rather than inherited gene changes.
Having a genetic risk is not necessarily a diagnosis
Changes in genes, known as genetic variants, are a normal part of being human and are common in the general population. Most do not have a direct effect on health and simply reflect natural human differences. For many genes, having a variant that is linked to a condition suggests a possible connection rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When a newborn has pulmonary interstitial emphysema, treatment usually focuses on breathing support rather than a medicine chosen by genetic testing. In most cases, genes do not directly determine which drug is used for pulmonary interstitial emphysema, because care often depends more on how premature the baby is, how much lung injury is present, and whether a ventilator is needed. Genetics is only one factor, and for many families the bigger treatment decisions involve lowering ventilator pressure, sometimes giving surfactant for the underlying lung problem, and watching closely for other air leaks. Rare inherited problems that affect lung development or surfactant proteins can make some babies more prone to severe lung disease, and that may shape the overall care plan, but it does not usually change a specific drug for pulmonary interstitial emphysema itself. So if you are wondering how genetics affect treatment for pulmonary interstitial emphysema, the short answer is that genetic testing is not a routine guide for medications here, though it may be considered if doctors suspect an underlying inherited lung disorder.
Interactions with other conditions
Pulmonary interstitial emphysema often appears in babies who already have fragile lungs, especially after severe breathing problems such as respiratory distress syndrome and the need for a ventilator. Day-to-day, it can feel like one health issue amplifies the other, because air leaking into the lung tissue can make oxygen levels harder to keep steady and can raise the amount of breathing support a baby needs. Pulmonary interstitial emphysema can also happen alongside a collapsed lung, and when both are present, breathing may worsen quickly and treatment usually becomes more urgent. Over time, babies with pulmonary interstitial emphysema may have a higher risk of developing long-term lung problems such as bronchopulmonary dysplasia, particularly if they were born very early or needed high levels of respiratory support. Doctors also watch closely for strain on the heart and blood vessels in the lungs, since low oxygen and ongoing lung injury can add to problems like pulmonary hypertension in some infants. Because the early symptoms of pulmonary interstitial emphysema can overlap with other newborn lung conditions, careful monitoring and coordinated care help the medical team tell what is driving the breathing trouble and how best to treat it.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Pulmonary interstitial emphysema?
Other lung problems can look a lot like pulmonary interstitial emphysema, especially in premature babies or babies who need help from a breathing machine. The main ones are a collapsed lung, other air leaks in the chest, newborn breathing distress caused by immature lungs, pneumonia, and longer-lasting lung irritation or injury linked to oxygen or ventilator support.
History
Pulmonary interstitial emphysema came into clearer view as newborn intensive care developed in the second half of the 20th century. Doctors caring for very premature or very sick babies began to notice a particular pattern: a baby on breathing support might suddenly need more oxygen, look more uncomfortable, or show uneven swelling of the lungs on a chest X-ray. At first, these changes were understood mainly as part of the broader “air leak” problems that can happen when fragile lungs are under pressure.
As medical science evolved, specialists recognized that this was a distinct condition in which air escapes from the tiny air sacs and tracks into the tissue between them. That mattered because pulmonary interstitial emphysema was not just another form of collapsed lung or trapped air around the lung. It helped explain why some babies became harder to ventilate even when the breathing machine settings had not changed much, and why the problem could affect one lung more than the other or spread unevenly through the chest.
Improvements in imaging helped move understanding forward. Chest X-rays gave the first clues, and later scans made the pattern easier to identify in difficult cases. Over time, doctors also learned more about who was most at risk, especially premature infants and babies who needed mechanical ventilation for severe lung disease. This led to gentler breathing strategies, closer monitoring, and changes in newborn intensive care aimed at lowering pressure-related lung injury.
The history of pulmonary interstitial emphysema is also tied to a broader shift in newborn medicine. As more extremely premature babies survived, teams gained more experience recognizing the early symptoms of pulmonary interstitial emphysema and separating it from other causes of sudden breathing trouble. Not every early description was complete, yet together they built the foundation of today’s knowledge. Many babies now benefit from earlier diagnosis and more careful lung-protective care than was possible in the past.